Related Experiment Video
Updated: Jun 23, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Transcatheter mitral and pulmonary valve therapy
Nicolo Piazza1, Anita Asgar, Reda Ibrahim
1Interventional Cardiology Department, Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands.
Journal of the American College of Cardiology
|May 16, 2009
Summary
Transcatheter valve therapies offer a less invasive treatment for valvular heart disease, especially for elderly patients and those with congenital heart conditions. This review updates on transcatheter mitral and pulmonary valve therapies, focusing on clinical status, applicability, and limitations.
Area of Science:
- Cardiology
- Medical Technology
- Geriatrics
Background:
- Global rise in elderly populations exacerbates the burden of valvular heart disease.
- Many patients with severe valve disease are denied conventional surgery due to age or comorbidities.
- Increasing numbers of adults with congenital heart disease require complex, high-risk procedures.
Purpose of the Study:
- To review the clinical status of transcatheter mitral and pulmonary valve therapies.
- To assess the applicability and limitations of these minimally invasive treatments.
- To provide an update on advancements in transcatheter valve interventions.
Main Methods:
- Review of current clinical data and literature on transcatheter mitral and pulmonary valve therapies.
- Analysis of patient populations including elderly and adults with congenital heart disease.
- Evaluation of procedural outcomes, morbidity, and mortality compared to conventional surgery.
Main Results:
- Transcatheter therapies aim for minimally invasive treatment with comparable efficacy to surgery.
- These approaches offer reduced morbidity and mortality for select patient groups.
- The review details the current clinical standing and practical use of these innovative treatments.
Conclusions:
- Transcatheter valve therapies represent a crucial advancement in managing valvular heart disease.
- These minimally invasive options are vital for elderly patients and those with complex congenital conditions.
- Continued research and development are essential to expand the applicability and refine the limitations of these therapies.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...